Ozempic is FDA-approved and generally safe when prescribed for its intended use in adults with type 2 diabetes, but it carries real risks that range from common digestive discomfort to rare but serious complications. The safety picture depends heavily on your individual health profile, whether you’re getting the brand-name product, and how closely you follow dosing guidelines.
What Ozempic Is Approved For
Ozempic (semaglutide) is approved for three specific uses in adults with type 2 diabetes: improving blood sugar control alongside diet and exercise, reducing the risk of major cardiovascular events like heart attack and stroke in people who also have heart disease, and protecting kidney function in people who also have chronic kidney disease. It is not FDA-approved for weight loss on its own, though a higher-dose version of the same drug (Wegovy) is approved for that purpose.
Common Side Effects
Digestive problems are by far the most frequent issue. Across clinical trials of semaglutide and similar drugs, roughly 23% of patients experienced nausea, 13% had diarrhea, 9% dealt with vomiting, and about 7% reported constipation. These side effects tend to be worst during the first weeks or after a dose increase, and they often improve as your body adjusts. Decreased appetite affects about 3% of users, which is part of how the drug works but can become a problem if it leads to inadequate nutrition.
Most people find these symptoms manageable, especially with a slow dose increase. But for some, the nausea and vomiting are severe enough to stop treatment.
The Thyroid Cancer Warning
Ozempic carries the FDA’s most serious type of warning, a boxed warning, about thyroid tumors. In animal studies, semaglutide caused tumors in thyroid C-cells, which are the cells involved in a rare cancer called medullary thyroid carcinoma. Whether this translates to humans isn’t fully established, but the risk was concerning enough for the FDA to act.
If you or a blood relative has ever been diagnosed with medullary thyroid carcinoma, or if you have a genetic condition called Multiple Endocrine Neoplasia syndrome type 2, you should not take Ozempic. These are the only absolute medical contraindications aside from a known allergy to semaglutide itself.
Serious but Less Common Risks
Pancreatitis, or inflammation of the pancreas, is a known concern with this class of drug. A large meta-analysis found that people taking these medications had roughly twice the risk of pancreatitis compared to those on a placebo, with an incidence of about 1%. Symptoms include severe abdominal pain that radiates to the back, often with vomiting. If you experience this, it requires immediate medical attention.
Kidney injury has also been flagged through post-marketing safety reports. Most cases appear to be linked to dehydration from severe vomiting or diarrhea rather than a direct toxic effect on the kidneys. Staying hydrated is especially important if you’re experiencing significant GI side effects.
A University of British Columbia study examining 16 million patient records found that people taking semaglutide or similar drugs had roughly 3.7 times the risk of gastroparesis (a condition where the stomach empties too slowly) and 4.2 times the risk of bowel obstruction compared to people taking a different weight-loss medication. These are uncommon but serious complications. Gastroparesis causes persistent nausea, vomiting, and abdominal pain. Bowel obstruction can sometimes require surgery.
Cardiovascular and Survival Benefits
On the positive side of the safety ledger, semaglutide has strong evidence for heart and kidney protection in people with type 2 diabetes. The FLOW trial, a large randomized study, found that semaglutide significantly reduced the risk of death from cardiovascular causes and major cardiovascular events in people with type 2 diabetes and chronic kidney disease. A separate observational study tracking over 27,000 patients for three years found that those on semaglutide had a 24% lower risk of death from any cause compared to those on another diabetes drug.
For people with type 2 diabetes and existing heart or kidney disease, these benefits are a meaningful part of the safety equation. The drug isn’t just “not harmful” for these patients; it appears to be actively protective.
Mental Health Concerns
Reports of suicidal thoughts in people taking semaglutide prompted the FDA to investigate. After reviewing adverse event reports, clinical trial data, and observational studies, the agency’s preliminary conclusion was that the evidence does not show a clear link between these drugs and suicidal thoughts or actions. However, the FDA noted it cannot definitively rule out a small risk and is continuing to monitor the issue. If you notice new or worsening depression or unusual mood changes while taking Ozempic, that’s worth reporting to your prescriber.
Pregnancy and Breastfeeding
Ozempic has not been adequately studied in pregnant humans. Animal studies showed possible harm to a developing fetus. It’s also unknown whether the drug passes into breast milk. If you’re planning to become pregnant, your doctor will likely recommend stopping Ozempic before conception, though no specific washout period is established in the prescribing label.
The Risks of Compounded Versions
This is one of the biggest safety concerns right now. Compounded semaglutide, the versions mixed by compounding pharmacies rather than manufactured by Novo Nordisk, has not undergone FDA review for safety, effectiveness, or quality. As of July 2025, the FDA had received 605 adverse event reports tied to compounded semaglutide, some requiring hospitalization.
The problems are varied and alarming. Some compounded products have arrived at incorrect storage temperatures, which can degrade the drug. Some contain salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from the approved drug, with unknown safety profiles. Dosing errors are common because patients must measure their own doses from vials rather than using pre-filled pens, and in some cases healthcare providers have miscalculated doses. The FDA has also identified fraudulent products with labels listing compounding pharmacies that don’t exist.
If you’re considering semaglutide, the brand-name FDA-approved product is significantly safer than compounded alternatives. The cost difference is real, but so is the risk.
Monitoring While on Ozempic
Taking Ozempic safely means ongoing check-ins, not just filling a prescription. If you have type 2 diabetes, your doctor will typically check your A1C (a measure of average blood sugar over the past few months) at least twice a year and may ask you to monitor blood sugar at home. Kidney function and pancreatic health should also be part of the conversation at regular visits, particularly if you’re experiencing persistent GI symptoms or have risk factors for those complications.
The slow dose escalation that Ozempic requires isn’t just a formality. Starting low and increasing gradually over weeks gives your body time to adjust and significantly reduces the severity of nausea and other digestive side effects. Skipping ahead to higher doses is one of the most common reasons people have a miserable experience with the drug.